The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-(3,4-Difluorobenzyl)-1H-pyrazol-3-yl)-2-(1-methyl-1H-indazol-5-yl)acetamide ID: ALA4203847
PubChem CID: 126740623
Max Phase: Preclinical
Molecular Formula: C20H17F2N5O
Molecular Weight: 381.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1ncc2cc(CC(=O)Nc3ccn(Cc4ccc(F)c(F)c4)n3)ccc21
Standard InChI: InChI=1S/C20H17F2N5O/c1-26-18-5-3-13(8-15(18)11-23-26)10-20(28)24-19-6-7-27(25-19)12-14-2-4-16(21)17(22)9-14/h2-9,11H,10,12H2,1H3,(H,24,25,28)
Standard InChI Key: GQWJSRCPJPOCIP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
47.0442 -16.4381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3396 -16.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6240 -16.4484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.3655 -15.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5442 -15.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2899 -16.4484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9570 -16.9304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.5826 -16.8603 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.8700 -16.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1589 -16.8630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4504 -16.4516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7411 -16.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7429 -15.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4522 -15.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8684 -15.6276 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
47.7541 -16.8423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.4582 -16.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.4489 -15.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.7296 -15.2039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.0284 -15.6235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
49.1512 -15.1870 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
49.1705 -16.8255 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.0281 -16.4636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0269 -15.6379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2413 -15.3839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7569 -16.0527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2433 -16.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9876 -14.6071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 2 0
6 5 1 0
7 6 2 0
3 7 1 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 23 1 0
24 13 1 0
13 14 2 0
14 11 1 0
9 15 2 0
1 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 1 1 0
18 21 1 0
17 22 1 0
23 24 2 0
24 25 1 0
25 26 1 0
26 27 2 0
27 23 1 0
25 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.39Molecular Weight (Monoisotopic): 381.1401AlogP: 3.28#Rotatable Bonds: 5Polar Surface Area: 64.74Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.30CX Basic pKa: 1.44CX LogP: 3.52CX LogD: 3.52Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -2.53
References 1. Bezençon O, Heidmann B, Siegrist R, Stamm S, Richard S, Pozzi D, Corminboeuf O, Roch C, Kessler M, Ertel EA, Reymond I, Pfeifer T, de Kanter R, Toeroek-Schafroth M, Moccia LG, Mawet J, Moon R, Rey M, Capeleto B, Fournier E.. (2017) Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies., 60 (23): [PMID:29116786 ] [10.1021/acs.jmedchem.7b01236 ]